NusaybaABagegniMD

PubMed

• Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.
  Whitney L Hensing, Lorenzo Gerratana, Katherine Clifton, Arielle J Medford, Marko Velimirovic, Ami N Shah, Paolo D'Amico, Carolina Reduzzi, Qiang Zhang, Charles S Dai,...> ;Clinical Cancer Research. 2023 Aug 15
• 2 citations
  A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
  Foluso O Ademuyiwa, Donald W Northfelt, Tracey O'Connor, Ellis Levine, Jingqin Luo, Yu Tao, Jeremy Hoog, Marie L Laury, Tracy Summa, Trish Hammerschmidt, Zhanfang Guo,...> ;NPJ Breast Cancer. 2023 Jan 6
• 4 citations
  Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer.
  Andrew A Davis, Lorenzo Gerratana, Katherine Clifton, Arielle J Medford, Marko Velimirovic, Whitney L Hensing, Leslie Bucheit, Ami N Shah, Paolo D'Amico, Carolina Redu...> ;Ebiomedicine. 2022 Dec 1
• 4 citations
  Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors.
  Nusayba A Bagegni, Haeseong Park, Katlyn Kraft, Maura O-Toole, Feng Gao, Saiama N Waqar, Lee Ratner, Daniel Morgensztern, Siddhartha Devarakonda, Manik Amin, Maria Q B...> ;Cancer Chemotherapy and Pharmacology. 2022 Apr 1
• 11 citations
  Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab.
  Nusayba A Bagegni, Andrew A Davis, Katherine K Clifton, Foluso O Ademuyiwa> ;Breast Cancer. 2022 Jan 1
• 4 citations
  Management of Diarrhea in Patients with HER2-Positive Breast Cancer Treated with Neratinib: A Case Series and Summary of the Literature.
  Megan L. Kruse, Irene M. Kang, Nusayba Bagegni, W. Todd Howell, Halle C. F. Moore, Cynthia H. Bedell, Christopher Stokoe> ;Oncology and Therapy. 2021 Nov 20
• 21 citations
  Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer
  Foluso O. Ademuyiwa, Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk, Gejae Jeffers, Zachary L. Skidmore, Anamika Basu, Megan Richters, Cynthia...> ;Breast Cancer Research and Treatment. 2021 Jun 26
• 8 citations
  Radiation-Induced Brachial Plexopathy in Patients With Breast Cancer Treated With Comprehensive Adjuvant Radiation Therapy.
  Soumon Rudra, Amit Roy, Randall Brenneman, Prashant Gabani, Michael C. Roach, L.L. Ochoa, Heidi Prather, Catherine M. Appleton, Julie A. Margenthaler, Lindsay L. Peter...> ;Advances in Radiation Oncology. 2021 Jan 1
• 2 citations
  Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA)
  Katherine Clifton, Jingqin Luo, Yu Tao, Jennifer Saam, Thereasa A. Rich, Anna Roshal, Ashley Frith, Caron Rigden, Foluso O. Ademuyiwa, Katherine N. Weilbaecher, Leonel...> ;Breast Cancer Research and Treatment. 2021 Feb 1
• 9 citations
  Age-related disparities in older women with breast cancer.
  Nusayba Bagegni, Lindsay L. Peterson> ;Advances in Cancer Research. 2020 Jan 1
• 33 citations
  Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database.
  Nusayba Bagegni, Yu Tao, Foluso O. Ademuyiwa> ;Plos One. 2019 Sep 19
• 118 citations
  Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.
  , , , , , , , , , , , , , , , , , , , , > ;Nature Communications. 2018 Jan 31
• 50 citations
  Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvan...
  Nusayba Bagegni, Shana Thomas, Ning Liu, Jingqin Luo, Jeremy Hoog, Donald W. Northfelt, Matthew P. Goetz, Andres Forero, Matthias Bergqvist, Jakob Karen, Magnus Neumul...> ;Breast Cancer Research. 2017 Nov 21
• Join now to see all